[AD/HD (attention deficit and hyperactivity syndrome) and methylphenidate].
Kaga
M
M
kaga@ncnp-k.go.jp
Miyamoto
S
S
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D017277:Drug Approval / Q000331:legislation & jurisprudence; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D009313:National Health Programs
D008774:Methylphenidate